Enabling-new-frontiers

    Enabling new frontiers to transform the lives of patients with rare diseases

    Data-driven patient insights enabling faster diagnosis and novel treatments to improve the quality of life of patients and their families

    Enable breakthrough innovations to infuse hope intothe lives of rare disease patients

    Enable-breakthrough-innovations (1)

    I too have dreams.
    I want to be someone.
    I want to go on to live a very full and rewarding life.

    – From a Rare Disease Patient

    More than 350 million people are affected by one of the 7,000+ rare diseases, with less than 5% having an approved treatment available. This huge unmet need in care and a commitment by manufacturers and regulators have instilled a sense of urgency to spur new scientific frontiers to transform the lives of patients with rare diseases.

    The immense challenges associated with a rare disease, a consequence of a very small patient population, mean a delayed diagnostic process, difficult access to treatment and care, and high social, emotional, and financial burden on patients and their family.

    Navigate these challenges and get commercialization support for rare disease treatments that create hope for patients, caregivers, and families.

    case-study-icon

    Read Blog / Challenges Of Accelerating Diagnostic Journeys For Rare Diseases

    Our capabilities in rare disease

    Sales analytics

    • Commercial model design
    • HCP and account-level segmentation
    • Promotional response analysis
    • Incentive plan design
    • Territory alignment
    • Call planning and targeting

    Marketing analytics

    • Launch planning
    • ROI of marketing programs
    • Digital engagement
    • Marketing mix modeling
    • Customer valuation
    • Campaign management

    Market access analytics

    • Payer rebate reporting tools
    • Specialty pharmacy performance
    • IDN segmentation
    • ROI analysis for managed markets tactics
    • Pricing and contract analysis

    Patient analytics

    • Understanding treatment protocols and the patient journey
    • Disease burden and cost of illness
    • Patient compliance and persistence
    • Drug utilization and patient profiling

    Axtria research hub

    White Paper

    Axtria MarketingIQ™ as a Scalable Self-Service Alternative to Custom MMx Tools

    Report

    Novel Drug Approvals by the U.S. Food and Drug Administration in Rare Diseases: Findings From 2020–2023

    Report

    Exploratory Data Analysis With Generative AI: A Patient Analytics Use Case

    Customer success stories

    Case Study

    Automated Email Campaigns Support The Patient Assistance Journey For Enhanced Treatment Outcomes

    Case Study

    Patient Flow Analysis For A Global Oncology Leader

    Case Study

    Enabling 95% Patient Adherence With Rapid Patient Data Analytics